Home Featured Page 234

Featured

Latest

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

Pα+ Psychedelic Bulletin #208: Psychedelic CEOs’ FDA Wish-List; APA Division 56 President Talks Psychedelics; Compass’ PTSD Study Published; Cybin Ousts Drysdale

BREAKING: FDA Publishes Lykos Therapeutics’ MDMA Complete Response Letter (CRL)

Albert Labs Announces a Distinguished Clinical and Scientific Advisory Board

Awakn Life Sciences Appoints Addiction Expert Prof. David Nutt as Chief...

Cybin Announces Former FDA Psychiatry Division Director Dr. Thomas Laughren has...

Exclusively-Natural Psychedelic Pharma Company, Filament Health, Lists on the NEO Exchange

Numinus Files U.S. Provisional Patent Application for a Proprietary Rapid Production...

Silo Wellness Debuts Marley One, the First Global Functional and Psychedelic...

Mydecine Selects Substance Use Disorder and Smoking Cessation for Novel Psychedelic...

Book Review: Alexander Shulgin’s The Nature of Drugs

Nova Mentis Autism Clinical Study Approved by Canadian Institutional Review Board

MYND Life Sciences Expands Intellectual Portfolio to Target Alzheimer’s disease and...

1...233234235...296 Page 234 of 296

EDITOR PICKS

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

Pα+ Psychedelic Bulletin #208: Psychedelic CEOs’ FDA Wish-List; APA Division 56 President Talks Psychedelics; Compass’ PTSD Study Published; Cybin Ousts Drysdale

BREAKING: FDA Publishes Lykos Therapeutics’ MDMA Complete Response Letter (CRL)

Albert Labs Announces a Distinguished Clinical and Scientific Advisory Board

Awakn Life Sciences Appoints Addiction Expert Prof. David Nutt as Chief...

Cybin Announces Former FDA Psychiatry Division Director Dr. Thomas Laughren has...

Exclusively-Natural Psychedelic Pharma Company, Filament Health, Lists on the NEO Exchange

Numinus Files U.S. Provisional Patent Application for a Proprietary Rapid Production...

Silo Wellness Debuts Marley One, the First Global Functional and Psychedelic...

Mydecine Selects Substance Use Disorder and Smoking Cessation for Novel Psychedelic...

Book Review: Alexander Shulgin’s The Nature of Drugs

Nova Mentis Autism Clinical Study Approved by Canadian Institutional Review Board

MYND Life Sciences Expands Intellectual Portfolio to Target Alzheimer’s disease and...

EDITOR PICKS

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY